Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Alteon receives U.S. patent for AGE cross-link breakers

Aug. 14, 1997

Alkermes issued U.S. patent for ProLease

Aug. 13, 1997

Trovert receives Orphan Drug designation for acromegaly

Aug. 13, 1997

Organon's fertility hormone approved in Canada

Aug. 13, 1997

Crinone approved in Mexico

Aug. 13, 1997

Cangene signs licensing and distribution agreement for Leucotropin

Aug. 12, 1997

RPR seeks U.S. and European approval for estrogen/progestogen transdermal patch

Aug. 12, 1997

Studies imply role of relaxin in infertility treatments

Aug. 12, 1997

Granocyte approved for marketing in 14 additional countries

Aug. 11, 1997

Analysis of Macritonin phase II/III trial complete; Cortecs to seek European approval

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...